Literature DB >> 16569768

Proteasome-dependent down-regulation of activated Stat5A in the nucleus.

Yuhong Chen1, Xuezhi Dai, Arthur L Haas, Renren Wen, Demin Wang.   

Abstract

A broad spectrum of cytokines can activate the signal transducer and activator of transcription 5 (Stat5) by inducing a single tyrosine phosphorylation of the molecule. Although the process of Stat5 activation has been well studied, the mechanism by which it is inactivated is not fully understood. We demonstrate that the proteasome inhibitor MG132, but not the nuclear export inhibitor leptomycin B (LMB), stabilizes active nuclear Stat5A, whereas MG132 only partially stabilizes active cytoplasmic Stat5A. Importantly, ubiquitinated Stat5A is detected in the nucleus and the polyubiquitination of active Stat5A is K48 linked, a linkage type targeting proteins for degradation. Ubiquitination of Stat5A is recapitulated in a cell-free system, and Ubc5 is identified as the E2-conjugating enzyme for Stat5A ubiquitination. Interestingly, phosphorylation of Stat5A per se is not required for ubiquitination. Finally, C-terminal deletion analysis of Stat5A localizes the amphipathic region of amino acids 751-762 as a ubiquitination signal, possibly representing an E3 recognition motif. Taken together, these results demonstrate that the down-regulation of nuclear and cytoplasmic active Stat5A is differentially regulated. In the nucleus, ubiquitin/proteasome-mediated protein degradation is the dominant mechanism for the down-regulation of active Stat5A, whereas in the cytoplasm, protein tyrosine phasphatase is a major player in the down-regulation of active Stat5A.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16569768      PMCID: PMC1895487          DOI: 10.1182/blood-2005-12-4777

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  57 in total

1.  A small amphipathic alpha-helical region is required for transcriptional activities and proteasome-dependent turnover of the tyrosine-phosphorylated Stat5.

Authors:  D Wang; R Moriggl; D Stravopodis; N Carpino; J C Marine; S Teglund; J Feng; J N Ihle
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

2.  Regulation of transcriptional activation domain function by ubiquitin.

Authors:  S E Salghetti; A A Caudy; J G Chenoweth; W P Tansey
Journal:  Science       Date:  2001-07-19       Impact factor: 47.728

Review 3.  Mechanisms underlying ubiquitination.

Authors:  C M Pickart
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

4.  Identification of Shp-2 as a Stat5A phosphatase.

Authors:  Yuhong Chen; Renren Wen; Shoua Yang; James Schuman; Eric E Zhang; Taolin Yi; Gen-Sheng Feng; Demin Wang
Journal:  J Biol Chem       Date:  2003-03-03       Impact factor: 5.157

5.  Distinct effects of STAT5 activation on CD4+ and CD8+ T cell homeostasis: development of CD4+CD25+ regulatory T cells versus CD8+ memory T cells.

Authors:  Matthew A Burchill; Christine A Goetz; Martin Prlic; Jennifer J O'Neil; Ian R Harmon; Steven J Bensinger; Laurence A Turka; Paul Brennan; Stephen C Jameson; Michael A Farrar
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

6.  Regulation of Stat3 nuclear export.

Authors:  Samita Bhattacharya; Christian Schindler
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

7.  Stat5 expression is critical for mast cell development and survival.

Authors:  Christopher P Shelburne; Margaret E McCoy; Roland Piekorz; Veronica Sexl; Kwan-Ho Roh; Sarah M Jacobs-Helber; Sheila R Gillespie; Daniel P Bailey; Paria Mirmonsef; Meredith N Mann; Mohit Kashyap; Harry V Wright; Hey Jin Chong; L Andrew Bouton; Brian Barnstein; Carlos D Ramirez; Kevin D Bunting; Steven Sawyer; Chris S Lantz; John J Ryan
Journal:  Blood       Date:  2003-04-24       Impact factor: 22.113

8.  Stat5B shuttles between cytoplasm and nucleus in a cytokine-dependent and -independent manner.

Authors:  Rong Zeng; Yutaka Aoki; Minoru Yoshida; Ken-ichi Arai; Sumiko Watanabe
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

9.  Identification of a nuclear Stat1 protein tyrosine phosphatase.

Authors:  Johanna ten Hoeve; Maria de Jesus Ibarra-Sanchez; Yubin Fu; Wei Zhu; Michel Tremblay; Michael David; Ke Shuai
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

10.  Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells.

Authors:  Heath L Bradley; Teresa S Hawley; Kevin D Bunting
Journal:  Blood       Date:  2002-07-25       Impact factor: 22.113

View more
  11 in total

1.  PARP-1 deficiency blocks IL-5 expression through calpain-dependent degradation of STAT-6 in a murine asthma model.

Authors:  R Datta; A S Naura; M Zerfaoui; Y Errami; M Oumouna; H Kim; J Ju; V P Ronchi; A L Haas; A H Boulares
Journal:  Allergy       Date:  2011-01-28       Impact factor: 13.146

2.  Transformation by E1A oncoprotein involves ubiquitin-mediated proteolysis of the neuronal and tumor repressor REST in the nucleus.

Authors:  Hancheng Guan; Robert P Ricciardi
Journal:  J Virol       Date:  2012-03-14       Impact factor: 5.103

3.  The tumor suppressor hTid1 inhibits STAT5b activity via functional interaction.

Authors:  Isabelle Dhennin-Duthille; Rémy Nyga; Saliha Yahiaoui; Valérie Gouilleux-Gruart; Aline Régnier; Kaïss Lassoued; Fabrice Gouilleux
Journal:  J Biol Chem       Date:  2010-11-24       Impact factor: 5.157

4.  Sestrin 2 protein regulates platelet-derived growth factor receptor β (Pdgfrβ) expression by modulating proteasomal and Nrf2 transcription factor functions.

Authors:  Ana Tomasovic; Nina Kurrle; Duran Sürün; Juliana Heidler; Koraljka Husnjak; Ina Poser; Frank Schnütgen; Susan Scheibe; Michael Seimetz; Peter Jaksch; Anthony Hyman; Norbert Weissmann; Harald von Melchner
Journal:  J Biol Chem       Date:  2015-02-25       Impact factor: 5.157

5.  Tumor necrosis factor receptor-associated factor 6 is an intranuclear transcriptional coactivator in osteoclasts.

Authors:  Shuting Bai; Jikun Zha; Haibo Zhao; F Patrick Ross; Steven L Teitelbaum
Journal:  J Biol Chem       Date:  2008-09-03       Impact factor: 5.157

Review 6.  The different functions of Stat5 and chromatin alteration through Stat5 proteins.

Authors:  Jan-Wilhelm Kornfeld; Florian Grebien; Marc A Kerenyi; Katrin Friedbichler; Boris Kovacic; Barbara Zankl; Andrea Hoelbl; Harini Nivarti; Hartmut Beug; Veronika Sexl; Mathias Muller; Lukas Kenner; Ernst W Mullner; Fabrice Gouilleux; Richard Moriggl
Journal:  Front Biosci       Date:  2008-05-01

7.  Proteasomes can degrade a significant proportion of cellular proteins independent of ubiquitination.

Authors:  James M Baugh; Ekaterina G Viktorova; Evgeny V Pilipenko
Journal:  J Mol Biol       Date:  2009-01-08       Impact factor: 5.469

8.  Phosphorylation of Bcl10 negatively regulates T-cell receptor-mediated NF-kappaB activation.

Authors:  Hu Zeng; Lie Di; Guoping Fu; Yuhong Chen; Xiang Gao; Langlai Xu; Xin Lin; Renren Wen
Journal:  Mol Cell Biol       Date:  2007-05-14       Impact factor: 4.272

9.  Calreticulin-mutant proteins induce megakaryocytic signaling to transform hematopoietic cells and undergo accelerated degradation and Golgi-mediated secretion.

Authors:  Lijuan Han; Claudia Schubert; Johanna Köhler; Mirle Schemionek; Susanne Isfort; Tim H Brümmendorf; Steffen Koschmieder; Nicolas Chatain
Journal:  J Hematol Oncol       Date:  2016-05-13       Impact factor: 17.388

10.  Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonists.

Authors:  Woubalem Birmachu; Raymond M Gleason; Barbara J Bulbulian; Christie L Riter; John P Vasilakos; Kenneth E Lipson; Yuri Nikolsky
Journal:  BMC Immunol       Date:  2007-10-12       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.